Dimension Therapeutics Appoints Successful Biopharma Leader Mary Thistle As Chief Business Officer

Dimension Therapeutics, Inc. (“Dimension” or the “Company”), a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, today announced that Mary Thistle, former senior vice president, business development at Cubist Pharmaceuticals, has been appointed to the newly created position of chief business officer. Ms. Thistle will report directly to Dimension’s CEO Annalisa Jenkins, MBBS, MRCP, and her appointment is effective February 2.

Help employers find you! Check out all the jobs and post your resume.